sb 203580 has been researched along with cysteamine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (cysteamine) | Trials (cysteamine) | Recent Studies (post-2010) (cysteamine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,307 | 60 | 666 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YJ; Kim, SJ; Yu, SM | 1 |
1 other study(ies) available for sb 203580 and cysteamine
| Article | Year |
|---|---|
PEP-1-glutaredoxin-1 induces dedifferentiation of rabbit articular chondrocytes by the endoplasmic reticulum stress-dependent ERK-1/2 pathway and the endoplasmic reticulum stress-independent p38 kinase and PI-3 kinase pathways.
Topics: Animals; Cartilage, Articular; Cell Dedifferentiation; Cell Differentiation; Chondrocytes; Chromones; Cysteamine; Endoplasmic Reticulum Stress; Glutaredoxins; Imidazoles; MAP Kinase Signaling System; Morpholines; Peptides; Phosphatidylinositol 3-Kinases; Pyridines; Rabbits | 2018 |